Subcutaneous Revolution: Alteogen and BD Showcase Large-Volume Biologic Delivery Solution
As the development of high-dose biologic therapies accelerates across the biopharmaceutical industry, innovative drug-delivery systems designed to...
Biowatch
Daewoong Pharmaceutical Acquires U.S. Cellular Reprogramming Tech to Fast-Track Anti-Aging Therapeutics
Daewoong Pharmaceutical is accelerating its research and development into anti-aging therapeutics. The company announced on the 21st that it has...
Oscotec Ramps Up R&D: What Lies Beyond the Success of Lazertinib?
“It doesn’t end with lazertinib. Keep an eye out for the next candidate in line.” Oscotec is aggressively channeling...
Rejuran Cosmetics Sales Surge 51%: PharmaResearch Finds New Growth Engine
PharmaResearch is successfully diversifying its business model, transitioning from a medical device-centric structure...
Seizure- and Recurrence-Prone Glioma: First New Drug in 20 Years
Being diagnosed with a brain tumor in your 30s or 40s—when you are building your career, raising children, and staying...
Celltrion to Acquire French Healthcare Specialist Gifrer, Eyeing European Pharmacy Market
Celltrion announced on the 12th its acquisition of Gifrer, a French healthcare specialist with a 114-year history.
Daewoong Pharmaceutical Moves to Develop Once-Monthly GLP-1 Obesity Injection
Daewoong Pharmaceutical is teaming up with a biotech startup to develop an obesity treatment administered by injection...
Samsung Bioepis Expands Global Open Innovation via Partnership With Chinese Biotech Hub
Samsung Bioepis announced on the 29th that it has signed a memorandum of understanding with Atlalt Innovation Center, a...
SCL Group and Hanaro Medical Foundation Accelerate K-Healthcare Expansion into Indonesia
SCL Group, a comprehensive healthcare solutions company led by Chairman Lee Kyung-ryul, is set to establish a strategic...
K-Pharma Sets Sights on Veterinary Market: Daewoong Pharmaceutical Leads the Charge
More than 10 South Korean pharmaceutical companies are pivoting toward veterinary medicine as a strategic growth engine.